Final guidance from the UK’s health technology assessor recommends that the country’s national healthcare provider fund Jakavi (ruxolitinib) in polycythaemia ve 14 September 2023
Belgian neuromuscular and neurodegenerative disorder specialist Augustine Therapeutics has made several executive appointments, including a new chief medical of 12 September 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.